Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.35 USD | +1.41% | -16.73% | -33.29% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.29% | 515M | |
+29.65% | 48.16B | |
-1.02% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.17% | 25.59B | |
-23.19% | 18.96B | |
+8.41% | 12.92B | |
+28.77% | 12.03B | |
-1.87% | 11.77B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- HC Wainwright Adjusts Price Target on Olema Pharmaceuticals to $22 From $17, Maintains Buy Rating